US Drug Watchdog Now Urges Families Of Diabetics Who Used The Diabetes...
The US Drug Watchdog says, "We are now urging family members of a diabetic who was using the diabetes drug called Actos, developed bladder cancer, and passed away to contact the Johnson Law...(PRWeb January 23, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10332648.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 23, 2013 Category: Pharmaceuticals Source Type: news
Actos Bladder Cancer Lawsuits: Next Status Conference in Federal...
Bernstein Liebhard LLP is currently investigating Actos lawsuits on behalf of individuals who developed bladder cancer following long-term use of the type 2 diabetes medication.(PRWeb January 20, 2013)Read the full story at http://www.prweb.com/releases/actos-lawsuits/actos-bladder-cancer/prweb10340351.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 21, 2013 Category: Pharmaceuticals Source Type: news
US Drug Watchdog Now Urges Families Mourning The Loss Of A Diabetic...
The US Drug Watchdog says,"We fear most of diabetics in the US, who took the diabetes drug called Actos, would never make the mental connection between their bladder cancer, and their use of the...(PRWeb January 18, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10313890.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 19, 2013 Category: Pharmaceuticals Source Type: news
Actos Lawsuit Update: New Case Management Order Establishes Protocol...
Bernstein Liebhard LLP is now investigating Actos bladder cancer lawsuits on behalf of individuals who developed bladder cancer following long-term use of Actos.(PRWeb January 14, 2013)Read the full story at http://www.prweb.com/releases/actos-lawsuits/actos-bladder-cancer/prweb10321068.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 14, 2013 Category: Pharmaceuticals Source Type: news
US Drug Watchdog Now Urges Diabetics Who Used the Diabetes Drug Actos...
The US Drug Watchdog is now saying, "We fear most diabetics, who used the diabetes drug called Actos, and then developed bladder cancer will never get compensated, so we are asking family members...(PRWeb January 14, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10313854.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 14, 2013 Category: Pharmaceuticals Source Type: news
US Drug Watchdog Now Urges Family Members Mourning The Loss Of A Loved...
The US Drug Watchdog says, "We are now urging families mourning the loss of a diabetic who died from bladder cancer to see if loved one diabetic was also using the diabetes drug called Actos. If...(PRWeb January 09, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10287452.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 10, 2013 Category: Pharmaceuticals Source Type: news
Horizon scanning: Four phase III studies investigating empagliflozin for type 2 diabetes meet primary end-point
Source: BioSpace.com
Area: News
BioSpace has reported that four late-stage trials evaluating empagliflozin for the treatment of type 2 diabetes met the primary goal of significantly lowering blood sugar levels.
The four pivotal studies from the empagliflozin trial program are:
. Study 1245.20 (n=986) evaluated 10 mg and 25 mg doses of empagliflozin as monotherapy versus placebo for 24 weeks.
. Study 1245.23 (n=1,504) compared 10 mg and 25 mg doses of empagliflozin as an add-on to metformin and metformin plus sulfonylurea versus placebo for 24 weeks.
. Study 1245.19 (n=499) assesse...
Source: NeLM - News - January 8, 2013 Category: Drugs & Pharmacology Source Type: news
US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug...
The US Drug Watchdog says, "We are urging any diabetic who used the diabetes drug called Actos, and have since been diagnosed with bladder cancer to call the Johnson law group for a legal review...(PRWeb January 07, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10287139.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 8, 2013 Category: Pharmaceuticals Source Type: news
Actos Lawsuits Move Forward with New Case Management Order, as...
A Case Management Order issued on January 2nd in the federal Actos litigation establishes a Periodic Review Process for administration of the lawsuits.(PRWeb January 05, 2013)Read the full story at http://www.prweb.com/releases/actos-lawsuits/actos-bladder-cancer/prweb10292626.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 5, 2013 Category: Pharmaceuticals Source Type: news
US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About...
The US Drug Watchdog intends to dramatically expand their initiative focused identifying diabetics, who used the diabetes drug called Actos, and then developed bladder cancer as the new year begins....(PRWeb January 03, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10259218.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 3, 2013 Category: Pharmaceuticals Source Type: news
Actos Bladder Cancer Lawsuit Set for Trial: Now, AttorneyOne can...
According to court documents, a lawsuit filed in the Superior Court of Los Angeles alleging bladder cancer caused by Actos is set to go on trial on February 19th, 2013. In light of these news,...(PRWeb January 03, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10284908.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 3, 2013 Category: Pharmaceuticals Source Type: news
